Ethnic psychopharmacology: the Hispanic and Native American perspective.

Department of Psychiatry, Harbor-UCLA Medical Center, Torrance 90509.
Psychopharmacology bulletin (Impact Factor: 0.5). 02/1991; 27(4):449-61.
Source: PubMed

ABSTRACT There is ample evidence attesting to differences in drug response and disposition among certain ethnic groups. The existing body of knowledge concerning pharmacological issues in the Hispanic and Native American ethnic groups, however, is both meager and confusing. In this article, the authors first attempt to briefly characterize these increasingly important ethnic groups, citing recent population figures and epidemiological findings. This is followed by a review of several existing retrospective studies concerning the pharmacological treatment of patients belonging to these groups. Recent findings in the area of pharmacogenetics are critically appraised and other factors influencing drug responsiveness are also examined. The clinical significance of this research for the optimal treatment of patients in cross-cultural settings is highlighted. The need for further research that would both fortify and clarify the available information with respect to these issues and the Hispanic and Native American populations is obvious.

  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Both drug therapy and psychosocial interventions have been shown to be effective treatments for psychiatric disorders. However, noncompliance with treatment regimens is a serious problem, and results in significant economic and psychosocial costs to the individual and society. Noncompliance can be caused by a number of factors, but can be positively affected by clinician-patient interactions and the patients’ knowledge of and readiness to undergo treatment. Patient preparedness in the form of education about treatment, in general, and medication, in particular, is likely to be associated with improved adherence to treatment, psychological well-being and quality of life.
    CNS Drugs 04/1995; 3(4). DOI:10.2165/00023210-199503040-00006 · 4.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The advent of the 21st century offers a unique opportunity for a reassessment of the epistemological bases of American psychiatry and its diverse components. The case of Hispanic/Latino psychiatry in the U.S. exemplifies the complexities of this process including a reaffirmation of its singular characteristics, and a struggle to gain recognition from and full acceptance into ‘mainstream’ psychiatry. After a brief review of the history of Hispanic communities in the U.S., relevant issues such as acculturation and the response of the host society to the waves of immigrants from ‘south of the border’ are discussed. The growth and increasing visibility of Hispanic psychiatry are demonstrated by an examination of existing organizations, workforce, academic enrollment and productivity, and the contributions of its Latin American and Spanish streams. The receptivity of American psychiatry and the accomplishments and failures on the way towards a true integration are assessed. The journey of Hispanic psychiatry from margin to mainstream will be based on the shaping of a true mestizo identity, continuous and consistent research contributions in specific areas, in-depth study of biocultural linkages in a variety of clinical phenomena, and the adoption by American psychiatry of a new form of universalism modeled after the genuine mestization process of its Hispanic component.
    Transcultural Psychiatry 03/2001; 38(1):5-25. DOI:10.1177/136346150103800102 · 0.99 Impact Factor